Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Cervical cancer
Trial Type:  Screening
Trial Status:  Active
Results 1-25 of 30 for your search:
Start Over
CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening (CITRUS Study)
Phase: Phase IV
Type: Screening
Status: Active
Age: 30 to 64
Sponsor: Pharmaceutical / Industry
Protocol IDs: TRIUC1312, UMIN000010843, NCT01895517
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
Phase: Phase III
Type: Screening
Status: Active
Age: 28 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 113617, NCT01190176
Combined Digital Colposcopy Analysis to Improve Cervical Precancer and Cancer Detection
Phase: Phase II
Type: Screening
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: BCCR-H09-03303, P01CA082710, H09-03303, NCT01094132
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Screening
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NU 99G8, P30CA060553, NCI-G00-1753, NU-99G7, NCT00005095
The Development of Human Papillomavirus Type 16 E7-Specific Human Immunologic Assays in Non-HLA2 Type Human Being
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Screening
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 9100208476, NCT00155792
Molecular Markers in Cervical Cancer Screening in the Feasibility of the Mathematical Markov Model Analysis
Phase: No phase specified
Type: Screening
Status: Approved-not yet active
Age: 25 to 65
Sponsor: Other
Protocol IDs: 320.6740, NCT00889902
HPV-cytology Testing Versus Cytology Testing for the Detection of High Grade CIN
Phase: No phase specified
Type: Screening
Status: Active
Age: 30 to 60
Sponsor: Other
Protocol IDs: UW09-377, NCT01058460
A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study
Phase: No phase specified
Type: Health services research, Prevention, Screening
Status: Active
Age: 18 to 26
Sponsor: Other
Protocol IDs: 33249, NCT01133509
Early Detection of Cancers in Low Resource Countries
Phase: No phase specified
Type: Diagnostic, Screening
Status: Approved-not yet active
Age: 30 to 64
Sponsor: Other
Protocol IDs: WCF-2011-BRA-IND-CAM, NCT01178736
Economic Evaluation of Three Populational Screening Strategies for Cervical Cancer
Phase: No phase specified
Type: Health services research, Screening
Status: Active
Age: 30 to 70
Sponsor: Other
Protocol IDs: PI10/01275, NCT01373723
Randomized Implementation of Primary HPV Testing in the Organized Screening for Cervical Cancer in Stockholm
Phase: No phase specified
Type: Screening
Status: Active
Age: 56 to 65
Sponsor: Other
Protocol IDs: SLL-KI-HPV, NCT01511328
Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening
Phase: No phase specified
Type: Diagnostic, Health services research, Screening
Status: Active
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: 7489, NCI-2013-00745, P30CA015704, R01CA157469, NCT01550783
Cervical Cancer Screening Project Part C
Phase: No phase specified
Type: Screening
Status: Active
Age: 25 to 70
Sponsor: Other
Protocol IDs: 2010NTLS097, NCT01575444
New Methods of Distribution of a Self Sampler Kit for Cervical Cancer Screening
Phase: No phase specified
Type: Screening
Status: Approved-not yet active
Age: 35 to 64
Sponsor: Other
Protocol IDs: NMD2TE, NCT01647724
Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2
Phase: No phase specified
Type: Screening
Status: Approved-not yet active
Age: 25 to 59
Sponsor: Other
Protocol IDs: cervicalscreening_mRNA_p16, NCT01837693
Cervical Cancer Screening With Human Papillomavirus Testing
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Screening
Status: Active
Age: 30 to 64
Sponsor: Other
Protocol IDs: IEC 12-27, NCT01881659
Overlooked Population at Risk for AIN.
Phase: No phase specified
Type: Natural history/Epidemiology, Screening
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: GYNEOCC 1, NCT01953094
The Kilimanjaro Cervical Screening Project
Phase: No phase specified
Type: Screening
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: DMED-1545-12, NCT01968837
HPV E6/E7 mRNA Versus HPV DNA as Triage for Cervical Cancer Screening
Phase: No phase specified
Type: Screening
Status: Active
Age: 30 to 65
Sponsor: Other
Protocol IDs: BT/PR6121/SPD/11/1401/2012, NCT02116920
Community-Driven Cervical Cancer Prevention in Western Kenya
Phase: No phase specified
Type: Health services research, Screening
Status: Approved-not yet active
Age: 25 to 65
Sponsor: Other
Protocol IDs: R01CA188428, NCT02124252
Research for Papillomavirus as the Examination of Orientation in the Organized Screening of the Cervical Cancer
Phase: No phase specified
Type: Screening
Status: Active
Age: 25 to 65
Sponsor: Other
Protocol IDs: RB 13.161 PapU-APV, NCT02137694
Prevalence of Anal Dysplasia and Cancer in Women
Phase: No phase specified
Type: Screening
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2014-0021, NCT02140021
Using CHWs or Mailing Self Sampling Home Tests to Increase Cervical Cancer Screening in South Florida
Phase: No phase specified
Type: Educational/Counseling/Training, Screening
Status: Active
Age: 30 to 65
Sponsor: Other
Protocol IDs: 20140249, 1R01CA183612-01, NCT02202109
The Effect of Early Versus Traditional Follow-Up on Breastfeeding Rates at 6 Months
Phase: No phase specified
Type: Screening
Status: Active
Age: 18 to 50
Sponsor: Other
Protocol IDs: 383665-1, NCT02221895
Cervical Cancer Screening in HIV Positive and Negative Women in Cambodia
Phase: No phase specified
Type: Natural history/Epidemiology, Screening
Status: Approved-not yet active
Age: 30 to 49
Sponsor: Other
Protocol IDs: SHCH-Cervical Screening-VIA, NCT02253719
Start Over